Details for New Drug Application (NDA): 215215
✉ Email this page to a colleague
The generic ingredient in DAPTOMYCIN is daptomycin. There are ten drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the daptomycin profile page.
Summary for 215215
Tradename: | DAPTOMYCIN |
Applicant: | Hangzhou Zhongmei |
Ingredient: | daptomycin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 215215
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 500MG/VIAL | ||||
Approval Date: | Nov 26, 2021 | TE: | AP | RLD: | No |
Complete Access Available with Subscription